CAS No.: 1222102-51-3
Evogliptin tartrate Catalog No. CSN20545
Synonyms: DA-1229 tartrate
Evogliptin tartrate is a potent and selective DPP4 inhibitor (dipeptidyl peptidase 4 inhibitor) which improves insulin resistance and delays the onset of diabetes.
| 规格 | 价格 | 促销价格 | 库存 | 数量 |
|---|
400-920-2911
sales@csnpharm.cn
tech@csnpharm.cn
纯度 & 质量文件
批次:
靶点选择性
生物活性
- 描述
- 参考文献
- [1] Kim TE, Lim KS, et al. Evaluation of the pharmacokinetics, food effect, pharmacodynamics, and tolerability of DA-1229, a dipeptidyl peptidase IV inhibitor, in healthy volunteers: first-in-human study. Clin Ther. 2012 Sep;34(9):1986-98.
- [2] Kim HJ, Kwak WY, et al. Discovery of DA-1229: a potent, long acting dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes. Bioorg Med Chem Lett. 2011 Jun 15;21(12):3809-12.
实验方案
- 计算器
- 储存液制备
技术信息
| CAS号 | 1222102-51-3 | 储存条件 |
|
|
| 分子式 | C23H32F3N3O9 | 运输 | 蓝冰 | |
| 分子量 | 551.51 | 别名 | DA-1229 tartrate |
